干细胞之家 - 中国干细胞行业门户第一站

 

 

搜索
中源协和

免疫细胞治疗专区

欢迎关注干细胞微信公众号

  
查看: 768141|回复: 0
go

Swimming with sperm [复制链接]

Rank: 7Rank: 7Rank: 7

积分
0 
威望
0  
包包
3465  
楼主
发表于 2009-3-5 23:38 |显示全部帖子 |倒序浏览 |打印
干细胞之家微信公众号
Clapham/Macmillan/ x$ r; y/ Q( |" [
) w) a9 E0 Q) S/ T, E
A putative calcium channel specific to sperm tails may be the best target yet for a male contraceptive. The protein, dubbed CatSper, was discovered in a homology search by David Clapham and colleagues of Harvard Medical School, Boston, MA.CatSper looks like a calcium channel, although Clapham could not detect a calcium current in transfected cells, probably because another component of the channel is missing. CatSper is, however, required for a calcium influx into sperm that is triggered by cyclic nucleotides. Such signaling events may be part of the process by which sperm either gain their initial motility in the epididymis, or augment that motility (in a process called hyperactivation) when they near an unfertilized egg.$ E! ^) J/ t% {- w3 ?
) X- R. B3 j5 v& N" q6 R3 o
Male mice lacking CatSper are completely infertile. Their sperm move sluggishly (at approximately one third of the normal rate) and can fertilize eggs only if the eggs have been stripped of their protective coat of zona pellucida.
3 O' D: k( V9 A2 Q2 q) N) z: T% O3 `
- M$ G; ]2 M" T0 T5 W- ABased on these data, says David Garbers (University of Texas Southwestern Medical Center, Dallas, TX), a CatSper inhibitor might be useful as a male contraceptive. "The problem with going after a male contraceptive is that you have millions of sperm and you have to get them all," he says. "Amazingly enough, when this channel was gone they got no fertilization. That makes it reasonably attractive as a drug target.". S% `* Y6 Q+ f. {; C* Z

+ @* }: |1 f$ e4 ]' xReference:
0 v$ A; l4 X% a- e% m1 t% E7 O( o3 g
/ w5 _3 H' A0 f, {; B2 }$ bRen, D., et al. 2001. Nature. 413:603–609.(CatSper revs up sperm tails.)
‹ 上一主题|下一主题 ›
你需要登录后才可以回帖 登录 | 注册
验证问答 换一个

Archiver|干细胞之家 ( 吉ICP备2021004615号-3 )

GMT+8, 2026-10-21 11:52

Powered by Discuz! X1.5

© 2001-2010 Comsenz Inc.